Search bioRxiv⌕ Search

Biology subjects

Hedan, B.

Publications and source records attributed to Hedan, B..

3 recordsLinked to original sources

Facilitating genome annotation using ANNEXA and long-read RNA sequencing

With the advent of complete genome assemblies, genome annotation has become essential for the functional interpretation of genomic data. Long-read RNA sequencing (LR-RNAseq) technologies have significantly improved transcriptome annotation by enabling full-length transcript reconstruction for both coding and non-coding RNAs. However, challenges such as transcript fragmentation and incomplete isoform representation persist, highlighting the need for robust quality control (QC) strategies. This study presents ANNEXA, a pipeline designed to enhance genome annotation using LR-RNAseq data while also providing QC for reconstructed genes and transcripts. ANNEXA integrates two transcriptome reconstruction tools, StringTie2 and Bambu, applying stringent filtering criteria to improve annotation accuracy. It also incorporates deep learning models to evaluate transcription start sites (TSSs) and employs the tool FEELnc for the systematic annotation of long non-coding RNAs (lncRNAs). Additionally, the pipeline offers intuitive visualisations for comparative analyses of coding and non-coding repertoires. Benchmarking against multiple reference annotations revealed distinct patterns of sensitivity and precision for both known and novel genes and transcripts and mRNAs and lncRNAs. To demonstrate its utility, ANNEXA was applied in a comparative oncology study involving LR-RNAseq of two human and eight canine cancer cell lines. The pipeline successfully identified novel genes and transcripts across species, expanding the catalog of protein-coding and lncRNA annotations in both species. Implemented in Nextflow for scalability and reproducibility, ANNEXA is available as an open-source tool: https://github.com/IGDRion/ANNEXA.

bioinformatics↗

Canine oral melanoma genomic and transcriptomic study defines two molecular subgroups with different therapeutical targets

Mucosal melanoma (MM) is a rare and aggressive clinical cancer that occurs mostly in the head, neck, and anogenital regions. Despite recent advances in genetics and the development of revolutionary treatments, such as immunotherapy, the prognosis for MM remains poor. Canine MM shares several clinical, histological, and genetic features with its human counterpart, offering a relevant spontaneous and immunocompetent model to decipher the genetic bases and explore treatment options for human MM. We performed an integrative genomic and transcriptomic analysis of 32 canine MM samples, which allowed us to identify two molecular subgroups differing in microenvironment and structural variant (SV) content. The overexpression of genes related to the microenvironment and T-cell response was associated with tumors harboring a lower content of structural variants, whereas the overexpression of pigmentation-related pathways and oncogenes such as TERT were associated with a high SV burden. To detail the SVs, especially those with focal amplifications, whole-genome sequencing was performed on four canine MM cell lines. We showed that focal amplifications characterized complex chromosomal rearrangements targeting oncogenes such as MDM2 or CDK4 and a recurrently amplified region on canine chromosome 30, comprising the genes TRPM7, GABPB1, USP8, and SPPL2A, were candidate oncogenes for MM. We showed that the copy numbers of these genes were significantly correlated with their expression levels. Finally, we demonstrated that the genes TRPM7, GABPB1, and SPPL2A play a role in cell proliferation; thus, these may be considered new candidate oncogenes for human MM. Our findings suggest the existence of two MM molecular subgroups that may benefit from dedicated therapies, such as immune checkpoint inhibitors or targeted therapies. These results illustrate the relevance of dog models for deciphering genetic mechanisms in spontaneous MM, along with the potential to screen for efficient targeted therapies for rare and aggressive cancers in humans.

cancer biology↗

Characterisation and functional predictions of canine long non-coding RNAs

Long non-coding RNAs (lncRNAs) are a family of heterogeneous RNAs that play major roles in multiple biological processes. We recently identified an extended repertoire of more than 10,000 lncRNAs of the domestic dog however, predicting their biological functionality remains challenging. In this study, we have characterised the expression profiles of 10,444 canine lncRNAs in 26 distinct tissue types, representing various anatomical systems. We showed that lncRNA expressions are mainly clustered by tissue type and we highlighted that 44% of canine lncRNAs are expressed in a tissue-specific manner. We further demonstrated that tissue-specificity correlates with specific families of canine transposable elements. In addition, we identified more than 900 conserved dog-human lncRNAs for which we show their overall reproducible expression patterns between dog and humans through comparative transcriptomics. Finally, co-expression analyses of lncRNA and neighbouring protein-coding genes identified more than 3,400 canine lncRNAs, suggesting that functional roles of these lncRNAs act as regulatory elements. Altogether, this genomic and transcriptomic integrative study of lncRNAs constitutes a major resource to investigate genotype to phenotype relationships and biomedical research in the dog species.

genomics↗